Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: Low inflammation and LDL oxidation in MHO women

International Journal of Obesity

Volumn 30, Issue 10, 2006, Pages 1529-1534

  Shin, M J ^a   Hyun, Y J ^a   Kim, O Y ^a   Kim, J Y ^a   Jang, Y ^a   Lee, J H ^a  

^a Yonsei University   (South Korea)

Author keywords

Inflammation; MHO; Visceral fat; Weight loss

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; LIPID STORAGE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OBESITY; OXIDATION; PRIORITY JOURNAL; WEIGHT REDUCTION;

ABDOMEN; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BODY FAT DISTRIBUTION; BODY MASS INDEX; C-REACTIVE PROTEIN; DIET, REDUCING; FEMALE; HUMANS; INFLAMMATION; INSULIN; LIPIDS; LIPOPROTEINS, LDL; MIDDLE AGED; OBESITY; OXIDATION-REDUCTION; TOMOGRAPHY, X-RAY COMPUTED; WEIGHT LOSS;

EID: 33749126980     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803304     Document Type: Article

References (30)

1. Must A, Spadano EH, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-1529.
2. National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med 2000; 160: 898-904.
3. Marchesini G, Melchionda N, Apolone G, Cuzzolaro M, Mannucci E, Corica F, et al., QUOVADIS Study Group. The metabolic syndrome in treatment-seeking obese persons. Metabolism 2004; 53: 435-440.
4. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Prevalence of uncomplicated obesity in an Italian obese population. Obes Res 2005; 13: 1116-1122.
5. Sims A. Are there persons who are obese, but metabolically healthy? Metabolism 2001; 50: 1499-1504.
6. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EAH et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001; 86: 1020-1025.
7. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004; 89: 2569-2575.
8. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. Insulin action and age. European group for the study of insulin resistance (EGIR). Diabetes 1996; 45: 947-953.
9. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European group for the study of insulin resistance (EGIR). J Clin Invest 1997; 100: 1166-1173.
10. Iacobellis G, Ribaudo MC, Leto G, Zappaterreno A, Vecci E, Mario UD et al. Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res 2002; 10: 767-773.
11. Iacobellis G. True uncomplicated obesity is not related to increased left ventricular mass and systolic dysfunction. J Am Coll Cardiol 2004; 44: 2257.
12. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prudhomme D et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145-4150.
13. National Cholesterol Education Program Expert Panel. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106: 3143-3421.
14. National Rural Living Science Institute. Food Composition Tables, 7th edn. National Rural Living Science Institute: Suwon, Korea, 2000 (in Korean).
15. Christian JL, Greger JH. Nutrition for Living. The Benjamin/Cummings Publishing Co Inc.: Menlo Park, CA, 1991; 111pp.
16. The American Dietetic Association. Handbook of Clinical Dietetics, 2nd edn. Yale University Press: New Haven, CT, 1992. pp 5-39.
17. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. Karelis AD. Clinical markers for the identification of metabolically healthy but obese individuals. Diabetes Obese Metab 2004; 6: 456-457.
19. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 1999; 99: 2221-2222.
20. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
21. Festa A, D'Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner S. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 1000; 102: 42-47.
22. McLauhglin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002; 106: 2908-2912.
23. Bastard JP, Jardel C, Bruckert E, Vidal H, Hainque B. Variations in plasma soluble tumor necrosis factor receptors after diet-induced weight loss in obesity. Diabetes Obese Metab 2000; 2: 323-325.
24. Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very low fat diets reduces C-reactive protein concentrations in obese-healthy women. Arterioscler Thromb Vasc Biol 2001; 1: 968-970.
25. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338-3342.
26. van Dielen FM, Buurman WA, Hadfoune M, Nijhuis J, Greve JW. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 2004; 89: 4062-4068.
27. Xydakis AM, Case CC, Jones PH, Hoogeveen RC, Liu MY, Smith EO et al. Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. J Clin Endocrinol Metab 2004; 89: 2697-2703.
28. Nicklas BJ, You T, Pahar M. Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. Can Med Assoc J 2005; 26: 172-179.
29. Oflaz H, Ozbey N, Mantar F, Genchellac H, Mercanoglu F, Sencer E et al. Determination of endothelial function and early atherosclerosis changes in healthy obese women. Diabetes Nutr Metab 2003; 16: 176-181.
30. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.